Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 30 (2) , 101-109
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)Radiation Oncology, 2013
- Aortic dose constraints when reirradiating thoracic tumorsRadiotherapy and Oncology, 2013
- Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Chest Reirradiation With External Beam Radiotherapy for Locally Recurrent Non-Small-Cell Lung Cancer: A ReviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Stereotactic Body Radiation Therapy for Patients With Lung Cancer Previously Treated With Thoracic RadiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Patterns of Radiotherapy Re-Treatment in Patients with Lung Cancer: A Retrospective, Longitudinal StudyJournal of Thoracic Oncology, 2007
- Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapyInternational Journal of Clinical Oncology, 2005
- Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non–small-cell lung cancer treated in stereotactic body frameInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999